SCHEMBL20599050

SCHEMBL20599050

CC(C)(C)OC(=O)N1C[C@H](O)C[C@@H](O[Si](C)(C)C(C)(C)C)C1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.43
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RECQL P46063 1/20 0.35
HPGD P15428 1/20 0.34
EPHX2 P34913 1/20 0.34
KDM4E B2RXH2 1/20 0.34
PIK3CD O00329 1/20 0.33
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
NAMPT P43490 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
EPHX1 P07099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18387460 1.00 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL20599053 1.00 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL18387513 1.00 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL16764762 1.00 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL16764759 1.00 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL9932807 1.00 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL13167071 0.88 NR1H2 (0.46) NR1H2USP2SMN1; SMN2RECQLHPGD
SCHEMBL16765553 0.85 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL31309202 0.85 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL16765554 0.85 NR1H2 (0.43) NR1H2CHRM2CHRM1CHRM3USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150362-A1 Substituted Pyrrolotriazines MOLECURE S.A. (PL) 2024-05-09 US disclosed
WO-2024042494-A1 SUBSTITUTED PYRROLOTRIAZINES MOLECURE SA (PL) 2024-02-29 WO disclosed
US-10703756-B2 Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereof PFIZER INC. (US) 2020-07-07 US disclosed
US-20190002466-A1 PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL, PYRROLO[2,3-B]PYRIDINYL ACRYLAMIDES AND EPOXIDES THEREOF PFIZER INC. (US) 2019-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190002466-A1 PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL, PYRROLO[2,3-B]PYRIDINYL ACRYLAMIDES AND EPOXIDES THEREOF JAK2, JAK3, JAK1 NR1H2 4812/4885CHRM2 4081/4885CHRM1 4289/4885
US-10703756-B2 Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereof JAK2, JAK3, JAK1 NR1H2 4812/4885CHRM2 4081/4885CHRM1 4289/4885
US-20240150362-A1 Substituted Pyrrolotriazines USP7, UBA7, USP5 NR1H2 2644/4885CHRM2 4811/4885CHRM1 4799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.